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doi:10.1016/j.fjs.2011.08.005Summary Epithelioid hemangioendothelioma (EHE) is a rare malignant neoplasm of endothe-
lial origin with an unpredictable clinical course and prognosis. Primary epithelioid hemangioen-
dotheliomas of the lung and pleura, in particular, are extremely rare. The clinical and
radiological manifestations mimic those of mesothelioma and metastatic adenocarcinoma,
and an accurate pathological diagnosis is important for appropriate clinical management.
Herein, we report one pulmonary and two pleural cases of epithelioid hemangioendothelioma.
All three patients were symptomatic at presentation. The symptoms included cough, dyspnea,
chest pain, and vocal palsy. Pleural effusion was noted in both pleural cases. Wedge resection
was performed in the patient with multiple pulmonary nodules. The postoperative recovery
was uneventful. The patient regained normal pulmonary function and was able to return to
work after the operation. Both patients with pleural lesions underwent surgical excision of
the tumors. Bony metastasis occurred in one of the patients and local recurrence developed
in the other. In the previously reported cases and our experience, pleural EHE tends to have
more aggressive behavior than tumors in other locations.
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Epithelioid hemangioendothelioma (EHE) is a rare, well-
differentiated vascular endothelial neoplasm. The clinical
behavior of EHE is between hemangioma and angiosarcoma.
Pulmonary involvement of EHE is even rarer. It was first
reported by Dail and Liebow in 1975 as an intravascular
bronchioloalveolar tumor.1 Four years later, Corrin et al2ciation. Published by Elsevier Taiwan LLC. All rights reserved.
164 Y.-Y. Chou et al.demonstrated using immunohistochemistry that EHE was
of endothelial origin. The tumor cells reacted to vascular
markers such as CD31, CD34, factor VIII, and Friend
leukemia integration-1 (FLI-1). Pulmonary EHE typically
manifests as bilateral multiple pulmonary nodules in young
or middle-aged women. Although many affected patients
are asymptomatic, some present with pleuritic pain,
dyspnea, and cough. We present a classic case of pulmo-
nary EHE in which the patient’s pulmonary function was
normal after operation.
EHE of the pleura is also extremely rare, and has a poor
prognosis because of aggressive involvement of the pleura
and the impossibility of complete surgical resection. The
radiological and histopathological characteristics resemble
those of metastatic adenocarcinoma or mesothelioma.
There are at present 12 reports of EHE of the pleura in the
literature.3 Herein, we report two more well-documented
cases of pleural EHE. Both patients underwent tumor
excision as well as radiotherapy and chemotherapy to treat
their recurrent or metastatic lesions. The pathological
diagnosis was independently confirmed by at least two
senior pathologists after reviewing hematoxylin-and-eosin-
stained tissue sections and immunohistochemical staining.
The ability to recognize and differentiate these tumors
based on the knowledge of their full morphological spec-
trum is important because they have different courses and
require different management strategies from those of
similar-looking tumors.
2. Case report
2.1. Clinical manifestations
2.1.1. Case 1
A 54-year-old man presented with a 1-month history of dry
cough after visiting a local medical hospital. The cough did
not abate, therefore, an X-ray was taken and showed
abnormal findings. Then, the patient was referred to our
chest outpatient department for further evaluation.
Computed tomography (CT) and positron emission tomog-
raphy (PET) scans revealed multiple small nodules
measuring up to 1.0 cm in diameter scattered throughout
both lung fields (Figure 1A). The nodules did not show
increased uptake of 2- [18F]-fluoro-2-deoxyglucose (FDG).
No other lesions suggestive of a primary disease were
found. The patient had normal pulmonary function [forced
vital capacity (FVC) 3.19 L and 100% predictive value
(PRED), forced expiratory volume in one second (FEV1)
2.69 L and 103% PRED, FEV1/FVC 84%]. The preliminary
diagnosis was pulmonary metastasis from an unknown
primary carcinoma. The patient, therefore, underwent
video-assisted thoracic surgery and wedge resection. The
postoperative chest X-ray did not show obvious progression
of lung nodules, and no chemotherapy or radiotherapy was
administered. The patient was able to return to work after
the operation and at 16 months’ follow-up there was no
evidence of disease recurrence.
2.1.2. Case 2
A 42-year-old man presented to a hospital elsewhere with
chest pain and a 6-month history of productive cough. AnX-ray and CT scan showed pleural effusion and irregular
thickness of the left pleura with small nodularities. The
preliminary diagnosis was mesothelioma or metastatic
carcinoma. A pleural biopsy was performed, and a defini-
tive diagnosis of plural EHE was made based on histopa-
thology of the biopsy specimen. The patient was
transferred to our thoracic surgical department. The CT
scan performed at that time revealed pleural thickness
with residual tumor (Figure 1B). Preoperative pulmonary
function testing revealed suboptimal pulmonary function,
but showed normal carbon monoxide diffusing capacity
(DLCO) (FVC 2.14 L and 59% PRED, FEV1 1.96 L and 65%
PRED; FEV1/FVC 91%, DLCO 22.0 mL/mm Hg/min, and 108%
PRED). The patient underwent pleurectomy. Intraoperative
findings included the presence of diffuse and irregular
thickening of the left visceral pleura with tight adhesion to
the parietal pleura. Fragmented pleural tissues measuring
up to 20.0 cm  5.0 cm  1.5 cm in size were removed.
Gross examination of the resected tissues showed grayish
cut surfaces with ill-defined firm nodules. At 5 months’
follow-up, metastatic bony lesions on the thoracic spine
were noted. The patient underwent radiotherapy and
chemotherapy, but did not respond well to treatment. At 14
months’ follow-up, the metastatic bony lesions were still
present.
2.1.3. Case 3
A 27-year-old man presented with a 3-month history of dry
cough, hoarseness, and chest tenderness. The CT scan
revealed a pleural mass and left hemidiaphragm paralysis
(Figure 1C and 1D). A PET scan showed increased uptake of
FDG. Intraoperative findings included a poorly defined,
fibrotic lesion measuring 3.7 cm  2.0 cm  2.0 cm in size in
the left pleura of the lung apex. The tumor adhered to the
internal jugular vein and carotid artery. It was partially
dissected and separated from the vessels. The patient
received postoperative radiotherapy with a radiation dose
of 6600 cGy in 33 fractions as initial therapy. However,
pleural effusion and tumor recurrence were noted 5 months
after the therapy. Pulmonary function tests showed
a restrictive ventilation defect but normal diffusing
capacity (standardized for alveolar volume) (FVC 2.32 L and
45% PRED, FEV1 2.02 L and 47% PRED, FEV1/FVC 87%,
DLCO/VA 5.47 mL/mm Hg/min/L and 117% PRED). The
patient then underwent pleurectomy and chemotherapy
with doxorubicin and cisplatin. He was monitored for 7
months after the pleurectomy and showed no evidence of
a new lesion. Nonetheless, the patient developed repeated
episodes of pneumonia and died of septicemia 18 months
after the initial diagnosis.
2.2. Pathologic findings
Three pulmonary nodules measuring up to 1.0 cm in diam-
eter were resected from Patient 1. The tumors were white
and elastic with a chondromyxoid consistency. Microscopi-
cally, the pulmonary nodules were made up of plump
epithelioid cells in a homogenous myxofibrous stroma
(Figure 2A). The tumors showed an intra-alveolar growth
pattern with tumor cells mainly in the alveolar spaces.
Some tumor cells had intracytoplasmic vacuoles containing
Figure 1 Computed tomography and X-ray. (A) Multiple small tumor nodules (arrows) in both lung fields (Patient 1). (B) Pleural
tumor (arrow) with irregular thickening of the left pleura (Patient 2). (C) A poorly defined nodule (arrow) in the apex of the left
pleura, with extension into the anterior mediastinum (Patient 3). (D) Chest X-ray showed elevation of the left diaphragm
(arrowhead) and tumor (arrow) in the paraspinal region of the left lung apex with increased opacity (Patient 3).
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endothelial differentiation.
The pleural tumors in Patients 2 and 3 were poorly
defined, with tan and relatively fibrous cut surfaces. The
microscopic features of the two pleural tumors were
similar. The hyalinized stroma was infiltrated by small nests
or cords of epithelioid cells (Figure 3A). The tumor cells had
uniform round or ovoid eccentric nuclei and a moderateFigure 2 Photomicrographs of pulmonary EHE (Patient 1). (A) Tum
original magnification 100). (B) Plump epithelioid tumor cells sho
(H&E, original magnification 400). EHE Z Epithelioid hemangioenamount of pink cytoplasm. Intracytoplasmic vacuoles and
mildly atypical nuclei were seen (Figure 3B). The most likely
differential diagnoses included metastatic adenocarcinoma,
malignant mesothelioma, or other rare pleural tumors.
Immunohistochemical studies were useful in making the
definitive diagnosis (Table 1). The tumors were positive
for endothelial markers, such as CD31, CD34 (Figure 4), or
FLI-1, supporting the diagnosis of EHE.or cells grew in alveolar spaces with myxofibrous stroma (H&E,
wed intracytoplasmic vacuoles containing erythrocytes (arrow)
dothelioma; H&E Z hematoxylin and eosin.
Figure 3 Photomicrographs of pleural EHE. (A) Scattered epithelioid nests (arrows) infiltrated fibrous pleural tissue, mimicking
mesothelioma (H&E, original magnification 100, Patient 2). (B) Luminal formation resembling metastatic adenocarcinoma.
Characteristic feature of EHE showed intracytoplasmic vacuoles with erytrocytes (arrows) inside them (H&E, original magnification
400, Patient 3). EHE Z Epithelioid hemangioendothelioma; H&E Z hematoxylin and eosin.
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EHE is a rare vascular tumor with intermediate malignant
potential, and occurs at a variety of tissue sites including
skin, soft tissue, liver, bone, and lung.4 Less common sites
include serosal membranes such as peritoneum and
pleura.5,6
In previously reported cases, pulmonary EHE occurred
predominantly in asymptomatic young women, in whom it
was diagnosed incidentally. In contrast, pleural EHE most
commonly affects older men, who are often symptomatic at
presentation.5 All three of our patients were men aged
27e54 years, and all presented with cough and chest pain.
Patient 3 experienced hoarseness due to left vocal cord
palsy, which is a rare presentation of pleural EHE.
In patients with pulmonary EHE, chest radiographs or
CT scans commonly show multiple, small nodular lesions in
both lungs, as in patient 1. Usually, metastatic carcinoma
or pulmonary hamartoma is suspected before pulmonary
biopsy or wedge resection is performed. Pleural EHE lacks
significant roentgenographic features, but manifests as
nodular or diffuse thickening of the pleura and pleural
effusion.5 A definitive preoperative diagnosis is difficult to
establish without biopsy.
Microscopically, pulmonary EHE usually features
epithelioid nests in a myxoid or chondroid stroma. The
differential diagnoses include metastatic adenocarcinomaTable 1 Primary antibodies and their application to examinatio
Antibodies Major reactivitya
CD31 Endothelial cell
CD34 Endothelial cell
FLI-1 Endothelial cell
AE1/AE3 Epithelial cells
Vimentin Mesenchymal cells
Calretinin Mesothelial cell
S-100 Peripheral nerve sheath cell, melanocyte, cho
Results: þ: positive reactivity; d: no reaction;
AE1/AE3 Z Cytokeratin AE1/AE3; FLI-1 Z Friend leukemia integratio
a Most antibodies have multiple applications. This column lists th
patients.and pulmonary hamartoma with chondroid elements. The
histological features most characteristic of EHE tumors are
intracytoplasmic vacuoles with red blood cells within the
lumens. EHE tumor cells are positive for endothelial
markers and are usually negative for epithelial and chon-
droid cell markers. Pleural EHE commonly displays fibrous
or hyalinized stroma with scant epithelioid cells, or occa-
sionally, spindle cells, arranged as small sheets, cords or
even glandular structures. In our patients, the differential
diagnoses included metastatic adenocarcinoma, malignant
mesothelioma, and sclerosing epithelioid fibrosarcoma.
Tumor cells of sclerosing epithelioid fibrosarcoma do not
react with epithelial or vascular markers. The specimens in
our patients were negative for cytokeratin and calretinin,
proteins that are usually expressed in carcinoma and meso-
thelioma. The reactivity to vascular markers confirmed the
diagnosis of EHE.
Immunohistochemistry is helpful in the diagnosis of EHE.
The endothelial markers characteristic of EHE include
CD31, CD34, factor VIII, and Ulex europaeus agglutinin 1
(UEA-1). CD31 and CD34 have also been shown to be
sensitive markers for the presence of endothelial differ-
entiation.6 The specimens from Patients 1 and 2 in our
series showed positive staining for both antibodies. Inter-
estingly, the tumor specimens in Patient 3 stained posi-
tively for CD 31 but negatively for CD34. A positive
immunohistochemical stain of FLI-1, recently reported asn
Patient 1 Patient 2 Patient 3
þ þ þ
þ þ d
ND ND þ
d d d
þ þ þ
ND d d
ndrocyte d ND d
n-1; ND Z not done.
e reactivity of antibodies used for differential diagnosis in our
Figure 4 Immunohistochemical study of tumor cells revealed
positive reactivity for CD34 (Avidin-Biotin-Complex method,
original magnification 400).
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diagnosis. Focally weak positivity of cytokeratin has been
described in cases of EHE.7 Although cytokeratin positivity
makes it difficult to differentiate EHE from carcinoma,
cytokeratin staining is usually focal and weaker than
vimentin staining. None of the tumor specimens from our
patients expressed cytokeratin.
Most EHE tissue samples display bland-looking nuclei and
nearly no mitotic activity. Occasionally, they exhibit areas
of nuclear atypia and mitoses (rarely more than 1 mf/10
high power fields), and/or focal necrosis. Such histological
features are correlated with a more aggressive clinical
course. Epithelioid angiosarcoma must be considered when
nuclear pleomorphism, increased mitotic figures, and
extensive necrosis are present.8
EHE is an indolent tumor with a tendency for local
recurrence and metastasis. Distant metastases are usually
seen in regional lymph nodes, liver, bowel, soft tissue, and
skin.7,9 The natural history of EHE is difficult to predict and
ranges from rapid progression to a silent course even
without treatment. Because of the rarity of pulmonary and
pleural EHE, there is no standard treatment for these
conditions. Complete surgical resection is the first choice
of treatment when possible. However, in most cases, the
lesions are multifocal or poorly defined, and curative
excision is impossible. Various investigators have reported
the use of radiotherapy or chemotherapy with doxoru-
bicin, vincristine, carboplatin, and etoposide for treat-
ment of inoperable or metastatic cases,10 and several
practitioners have reported partial or complete remission
with interferon.
The 5-year survival rate for patients with pulmonary EHE
is about 60% (range, 45e71%). The presence of anemia,
weight loss, pulmonary symptoms, and especially hemor-
rhagic effusion, are associated with poorer prognoses.10 In
our series, Patient 1 had no significant history of poor
prognostic factors. He had a smooth postoperative course
and returned to work after the operation. In our experi-
ence, and according to the literature, however, pleural EHE
tends to have a more aggressive clinical course.5,8 There
were no obvious mitotic figures or tumor necrosis in thepleural tumors in Patients 2 and 3, but Patient 2 developed
metastasis to the thoracic spine, which responded poorly to
radiotherapy and chemotherapy. Patient 3 required radio-
therapy and chemotherapy with doxorubicin and cisplatin
for treatment of a recurrent lesion. The patient’s pleural
effusion resolved and there was no new growth after six
courses of chemotherapy. Unfortunately, the patient
developed repeated episodes of pneumonia and died of
septicemia 18 months after the initial diagnosis.
In summary, the clinical features of pleural EHE differ
from those of pulmonary EHE. Pleural EHE usually develops
in men, who are symptomatic at presentation, and has
a more aggressive clinical course than EHE arising in the
lung or other sites.5,8 The clinical, radiological, and histo-
morphological features of EHE mimic those of metastatic
adenocarcinoma and malignant mesothelioma, but the
management and prognosis of those tumors are significantly
different from the tumors they mimic. EHE must be sus-
pected in cases of pleural epithelioid tumors that do not
exhibit cytokeratin. Acute awareness of the morphologic
features and immunohistochemical characteristics of EHE
will help establish an accurate diagnosis of this tumor.Acknowledgments
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